TY  - JOUR

T1  - Modeling the selective growth advantage of genetically variant human pluripotent stem cells to identify opportunities for manufacturing process control

JO  - Cytotherapy

UR  - https://eprints.whiterose.ac.uk/id/eprint/232722

PY  - 2024/02/11

AU  - Beltran-Rendon C

AU  - Price CJ

AU  - Glen K

AU  - Stacey A

AU  - Barbaric I

AU  - Thomas RJ

ED  - 

DO  - DOI: 10.1016/j.jcyt.2024.01.010

PB  - Elsevier BV

VL  - 26

IS  - 4

SP  - 383

EP  - 392

Y2  - 2025/11/28

ER  -